Canada approved Amylyx Pharmaceuticals Inc.’s new drug for amyotrophic lateral sclerosis last week. Now some U.S. patients with the fatal neurodegenerative disorder—also known as Lou Gehrig’s disease—are considering a trip north to get the medication, Albrioza. The drug isn’t approved in the U.S.
William Woods, a 75-year-old retired doctor in Atlanta who was diagnosed with ALS in 2019, is contacting Canadian doctors who might help him get Albrioza. “There is a lot to figure out,” he said, “but I am confident I will find somebody I can go see.”
![‘Survivor 47’ Finale Recap Part 2, [Spoiler] Wins](https://tvline.com/wp-content/uploads/2024/12/survivor-finale-part-2-cbs.jpg?w=650 "‘Survivor 47’ Finale Recap Part 2, [Spoiler] Wins")
